Catastrophism in Chronic Inflammatory Rheumatism (CRIC)
Chronic Inflammatory Rheumatism
About this trial
This is an interventional diagnostic trial for Chronic Inflammatory Rheumatism focused on measuring Catastrophism
Eligibility Criteria
Inclusion Criteria:
- Major patients, hospital follow-up, with RA according to ACR 2010 criteria, or spondyloarthritis according to ASAS 2009 criteria or according to AMOR or psoriatic arthritis according to Caspar 2006 criteria.
- Patient who has given free and informed consent.
- Patient who has signed the consent form.
- Patient affiliated or benefiting from a health insurance plan.
- Adult patient (≥18 years old).
Exclusion Criteria:
- Patient under the protection of justice, under guardianship or curatorship.
- Patient unable to express consent.
- Patient for whom it is impossible to provide informed information.
- Poor command and understanding of the French language making it impossible to complete self-questionnaires
Sites / Locations
- CHU de Montpellier
- CHU de Nîmes
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
Experimental
rheumatoid arthritis
spondyloarthritis
Psoriatic arthritis
Filling in several self-questionnaires: on function (HAQ), pain EVA, quality of life (SF12, EQ5D), anxiety score (GAD-7), insomnia score (ISI), catastrophic score (PCS), coping score (coping ability, CSQ), compliance scores (CQR, Health Insurance Compliance Assessment Questionnaire) and fibromyalgia diagnostic score (FiRST), activity of rheumatic disease (RAID, RAPID-3) Patients will be seen at 3, 6 and 12 months
Filling in several self-questionnaires: on function (HAQ), pain EVA, quality of life (SF12, EQ5D), anxiety score (GAD-7), insomnia score (ISI), catastrophic score (PCS), coping score (coping ability, CSQ), compliance scores (CQR, Health Insurance Compliance Assessment Questionnaire) and fibromyalgia diagnostic score (FiRST), activity of rheumatic disease (BASDAI, BASFI). Patients will be seen at 3, 6 and 12 months
Filling in several self-questionnaires: on function (HAQ), pain EVA, quality of life (SF12, EQ5D), anxiety score (GAD-7), insomnia score (ISI), catastrophic score (PCS), coping score (coping ability, CSQ), compliance scores (CQR, Health Insurance Compliance Assessment Questionnaire) and fibromyalgia diagnostic score (FiRST), activity of rheumatic disease (BASDAI, BASFI). Patients will be seen at 3, 6 and 12 months